​

Rocket Pharmaceuticals (RCKT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Rocket Pharmaceuticals Revenue Highlights

00

Rocket Pharmaceuticals Revenue by Period

Rocket Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Rocket Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Rocket Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$9.19M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$10.31M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31--

Rocket Pharmaceuticals generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Rocket Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IMABI-Mab$27.64M$1.10M
AUTLAutolus Therapeutics$10.12M$21.14M
QSIQuantum-Si$3.06M$552.00K
DSGNDesign Therapeutics--
SLDBSolid Biosciences--
AURAAura Biosciences--
RCKTRocket Pharmaceuticals--
ANNXAnnexon--
LBRXLB Pharmaceuticals--
DBVTDBV--
GALTGalectin Therapeutics--

RCKT Revenue FAQ

What is Rocket Pharmaceuticals’s yearly revenue?

Rocket Pharmaceuticals's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. RCKT's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Rocket Pharmaceuticals’s quarterly revenue?

Rocket Pharmaceuticals's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). RCKT's quarterly revenue for Q4 2024 was $9.19M, a 100.00% increase from the previous quarter (Q3 2024), and a -10.92% decrease year-over-year (Q4 2023).

What is Rocket Pharmaceuticals’s revenue growth rate?

Rocket Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.